Please provide your email address to receive an email when new articles are posted on . Cencora completed its acquisition of Retina Consultants of America, according to a press release.

Wells Fargo lowered the firm’s price target on Cencora (COR) to $237 from $249 ... and price targets for the drug distribution group following the results and recent mergers.

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced the appointment of Francois Mandeville as Executive Vice President of Strategy and M&A, and Pawan Verma as Executive Vice President and ...

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced a definitive agreement to acquire Retina Consultants of America ...

Jan 2 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its annual adjusted profit forecast on Thursday, citing benefits from its $4.4 billion takeover of Retina Consultants of ...

UBS Group boosted their price target on shares of Cencora from $275.00 to $285.00 and gave the company a “buy” rating in a research report on Thursday, November 7th.

Cencora, Inc. (COR), headquartered in Pennsylvania, is a global pharmaceutical sourcing and distribution leader offering innovative healthcare solutions and services. With a market cap of $45.2 ...